Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,880,931
-
Share change
-
+3,587,239
-
Total reported value
-
$17,887,000
-
Put/Call ratio
-
6.9%
-
Price per share
-
$4.61
-
Number of holders
-
22
-
Value change
-
+$16,571,260
-
Number of buys
-
17
-
Number of sells
-
5
Institutional Holders of VASCULAR BIOGENICS LTD - COM (VBLT) as of Q2 2016
As of 30 Jun 2016,
VASCULAR BIOGENICS LTD - COM (VBLT) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,880,931 shares.
The largest 10 holders included
First Eagle Investment Management, LLC, FRANKLIN RESOURCES INC, Knoll Capital Management, LP, Migdal Insurance & Financial Holdings Ltd., MACQUARIE GROUP LTD, TURNER INVESTMENTS, L.P., MORGAN STANLEY, MENTA CAPITAL LLC, IFP Advisors, Inc, and Schonfeld Strategic Advisors LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.